Complete Filing Data
InMed Pharmaceuticals Inc. reported Stockholders Equity of $12.09 million for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean InMed Pharmaceuticals Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cost of Revenue * | $3.2M | $3.5M | $2.7M | $545.9K | ||
| Net Income Loss | -$8.2M | -$7.7M | -$7.9M | -$18.6M | -$10.2M | -$8.9M |
| Research And Development Expense | $2.9M | $3.2M | $3.7M | $7.3M | $5.3M | $5.8M |
| Operating Expenses | $9.7M | $9.3M | $9.8M | $17.8M | $9.9M | $9.2M |
| General And Administrative Expense | $6.6M | $5.8M | $5.8M | $6.9M | $4.5M | $3.2M |
| Revenues | $4.9M | $4.6M | $4.1M | $1.1M | ||
| Gross Profit | $1.7M | $1.1M | $1.4M | $543.5K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$8.2M | -$7.7M | -$7.9M | -$18.6M | ||
| Comprehensive Income Net Of Tax | -$18.6M | -$9.8M | -$9.4M | |||
| Loss And Comprehensive Incomelosses For The Period | -$9.8M | -$9.4M | ||||
| Interest Income Expense Net | -$360.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue * | $636.0K | $717.0K | $1.1M | $650.8K | $771.2K | $883.1K | $916.1K | $880.6K | $841.4K | $338.6K | $235.0K | $127.3K | $153.5K | |||||||
| Net Income Loss | -$2.0M | -$1.7M | -$2.1M | -$2.6M | -$1.7M | -$1.7M | -$1.5M | -$2.5M | -$2.0M | -$2.1M | -$3.5M | -$3.5M | -$4.3M | -$3.0M | -$3.1M | -$2.2M | -$1.6M | -$2.0M | -$2.5M | -$2.8M |
| Research And Development Expense | $630.6K | $581.6K | $909.7K | $895.2K | $700.1K | $656.8K | $609.8K | $1.3M | $878.3K | $851.4K | $1.4M | $1.8M | $2.5M | $1.5M | $1.8M | $937.9K | $911.2K | $1.3M | $1.6M | $2.0M |
| Operating Expenses | $2.3M | $2.2M | $2.3M | $2.7M | $2.2M | $2.1M | $2.0M | $2.7M | $2.3M | $2.3M | $3.1M | $3.7M | $4.4M | $2.9M | $3.1M | $1.9M | $1.6M | $2.2M | $2.5M | $2.9M |
| General And Administrative Expense | $1.6M | $1.5M | $1.3M | $1.7M | $1.5M | $1.4M | $1.4M | $1.3M | $1.4M | $1.5M | $1.6M | $1.9M | $1.8M | $1.4M | $1.3M | $959.6K | $624.8K | $902.3K | $871.7K | $887.5K |
| Revenues | $820.2K | $1.1M | $1.3M | $1.1M | $1.3M | $1.2M | $1.2M | $901.9K | $1.0M | $469.8K | $320.8K | $309.6K | $265.1K | |||||||
| Gross Profit | $184.2K | $403.2K | $175.6K | $460.9K | $493.4K | $289.5K | $324.1K | $21.2K | $192.5K | $131.2K | -$491.0K | $182.3K | $111.6K | |||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.0M | -$1.7M | -$2.1M | -$2.6M | -$1.7M | -$1.7M | -$1.5M | -$2.5M | -$2.0M | -$2.1M | -$3.5M | -$3.5M | -$4.3M | -$3.0M | ||||||
| Comprehensive Income Net Of Tax | -$2.0M | -$2.1M | -$3.5M | -$3.5M | -$4.3M | -$3.0M | -$3.1M | -$1.9M | -$1.5M | -$2.7M | -$2.1M | -$3.1M | ||||||||
| Loss And Comprehensive Incomelosses For The Period | -$1.9M | -$1.5M | -$2.7M | -$2.1M | -$3.1M | |||||||||||||||
| Interest Income Expense Net | -$1.5K | -$3.0K | -$6.8K | -$360.4K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $12.1M | $9.1M | $7.4M | $5.9M | $14.2M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $8.9M | $6.2M | $7.4M | $5.8M | |||
| Cash And Cash Equivalents At Carrying Value | $6.6M | $8.9M | $6.2M | $5.8M | $9.8M | ||
| Short Term Investments | $43.1K | $44.4K | $44.8K | $46.5K | $42.4K | ||
| Retained Earnings Accumulated Deficit | -$109.1M | -$101.4M | -$93.5M | -$74.9M | -$64.6M | ||
| Prepaid Expense And Other Assets Current | $477.7K | $498.0K | $797.2K | $956.8K | $418.9K | ||
| Operating Lease Liability Current | $317.8K | $375.7K | $404.3K | $80.5K | $69.0K | ||
| Liabilities Current | $2.0M | $2.0M | $3.3M | $2.2M | $1.7M | ||
| Liabilities And Stockholders Equity | $11.8M | $14.1M | $12.8M | $9.8M | $7.8M | ||
| Liabilities | $2.6M | $2.0M | $3.7M | $2.4M | $1.9M | ||
| Common Stock Value | $82.8M | $77.6M | $70.7M | $60.6M | $53.1M | ||
| Assets Current | $8.7M | $11.3M | $9.6M | $8.4M | $6.3M | ||
| Assets | $11.8M | $14.1M | $12.8M | $9.8M | $7.8M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $128.6K | $128.6K | $128.6K | $128.6K | -$301.9K | ||
| Accounts Receivable Net Current | $352.8K | $260.4K | $88.0K | $11.9K | $45.3K | ||
| Accounts Payable And Accrued Liabilities Current | $1.7M | $1.6M | $2.4M | $2.1M | $1.6M | ||
| Operating Lease Liability Noncurrent | $644.9K | $16.0K | $389.5K | $189.3K | $248.0K | ||
| Intangible Assets Net Excluding Goodwill | $1.8M | $1.9M | $2.1M | $1.1M | $1.1M | ||
| Property Plant And Equipment Net | $1.2M | $723.4K | $403.5K | ||||
| Other Assets Noncurrent | $100.0K | $104.9K | $176.6K | $14.7K | |||
| Inventory Net | $1.2M | $1.6M | $2.5M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$2.3M | $2.7M | -$1.2M | $1.6M | -$4.0M | ||
| Operating Lease Right Of Use Asset Amortization Expense | $321.9K | $384.9K | $393.7K | $326.1K | |||
| Inventory Write Down | $305.8K | $308.9K | |||||
| Repayments Of Long Term Capital Lease Obligations | $426.6K | $341.9K | $94.0K | $72.5K | |||
| Operating Lease Expense | $326.1K | $107.8K | $89.8K | ||||
| Additional Paid In Capital Common Stock | $35.4M | $35.7M | |||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $187.2K | $968.4K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $4.5M | -$2.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $9.6M | $11.6M | $13.4M | $7.0M | $6.2M | $8.4M | $9.2M | $11.1M | $12.8M | -$9.6M | $12.4M | $14.3M | $11.0M | $10.9M | $14.2M | $15.2M | $10.4M | $7.6M | $4.5M | $7.1M | $9.6M | $11.5M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $7.0M | $9.3M | $11.1M | $4.7M | $3.4M | $5.6M | $6.6M | $7.6M | $9.5M | $6.7M | $9.6M | $11.5M | $9.4M | $5.9M | $11.3M | $15.3M | $9.5M | $10.0M | $4.5M | $7.0M | $9.2M | $11.0M | ||
| Cash And Cash Equivalents At Carrying Value | $7.0M | $9.3M | $11.1M | $4.7M | $3.4M | $5.6M | $7.6M | $9.5M | $6.7M | $9.6M | $11.5M | $9.4M | $5.9M | $11.3M | $15.3M | $7.4M | $9.5M | $10.0M | $4.5M | |||||
| Short Term Investments | $42.7K | $42.9K | $43.4K | $40.6K | $40.8K | $43.2K | $43.1K | $44.5K | $42.9K | $43.1K | $43.1K | $42.1K | $46.1K | $45.4K | $45.2K | $45.8K | $45.2K | $43.2K | ||||||
| Retained Earnings Accumulated Deficit | -$121.0M | -$119.0M | -$117.2M | -$115.4M | -$113.3M | -$110.8M | -$107.1M | -$105.4M | -$103.9M | -$101.1M | -$99.1M | -$97.0M | -$85.6M | -$82.1M | -$77.8M | -$71.6M | -$68.5M | -$66.2M | ||||||
| Prepaid Expense And Other Assets Current | $660.3K | $191.8K | $321.7K | $507.9K | $644.0K | $148.9K | $1.0M | $1.1M | $215.0K | $695.2K | $826.9K | $356.7K | $1.3M | $140.5K | $322.4K | $1.3M | $28.5K | $524.2K | ||||||
| Operating Lease Liability Current | $408.1K | $424.8K | $435.5K | $429.2K | $419.7K | $424.3K | $345.5K | $364.2K | $293.0K | $423.6K | $414.3K | $404.2K | $399.9K | $391.8K | $82.2K | $78.8K | $76.3K | $71.4K | ||||||
| Liabilities Current | $1.5M | $1.6M | $1.8M | $1.8M | $1.8M | $1.4M | $1.5M | $1.7M | $1.3M | $2.3M | $2.4M | $3.3M | $4.1M | $4.6M | $1.9M | $1.7M | $2.2M | $1.9M | ||||||
| Liabilities And Stockholders Equity | $11.2M | $13.4M | $15.6M | $9.3M | $8.5M | $10.5M | $13.4M | $15.3M | $10.9M | $14.7M | $16.9M | $14.6M | $15.5M | $19.4M | $17.3M | $12.3M | $11.7M | $6.6M | ||||||
| Liabilities | $1.6M | $1.8M | $2.1M | $2.3M | $2.3M | $2.1M | $2.3M | $2.5M | $1.3M | $2.3M | $2.6M | $3.6M | $4.6M | $5.2M | $2.1M | $1.9M | $4.2M | $2.1M | ||||||
| Common Stock Value | $92.0M | $91.8M | $91.2M | $87.5M | $84.5M | $84.2M | $80.6M | $79.9M | $77.6M | $77.6M | $74.9M | $72.7M | $69.8M | $69.1M | $63.7M | $60.6M | $58.0M | $53.1M | ||||||
| Assets Current | $8.8M | $10.8M | $12.9M | $6.4M | $5.5M | $7.3M | $10.1M | $11.8M | $8.3M | $11.8M | $14.0M | $11.5M | $8.7M | $12.5M | $16.0M | $10.9M | $10.2M | $5.1M | ||||||
| Assets | $11.2M | $13.4M | $15.6M | $9.3M | $8.5M | $10.5M | $13.4M | $15.3M | $10.9M | $14.7M | $16.9M | $14.6M | $15.5M | $19.4M | $17.3M | $12.3M | $11.7M | $6.6M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | -$172.5K | ||||||
| Accounts Receivable Net Current | $183.0K | $343.5K | $465.1K | $367.8K | $262.6K | $284.7K | $207.7K | $372.9K | $165.9K | $170.3K | $81.6K | $15.2K | $70.6K | $50.3K | $14.8K | $70.3K | $154.8K | $51.9K | ||||||
| Accounts Payable And Accrued Liabilities Current | $1.1M | $1.1M | $1.4M | $1.4M | $1.4M | $1.0M | $1.2M | $1.3M | $1.0M | $1.8M | $2.0M | $2.4M | $2.9M | $3.4M | $1.8M | $1.6M | $2.1M | $1.8M | ||||||
| Operating Lease Liability Noncurrent | $123.8K | $215.5K | $305.8K | $419.3K | $529.2K | $633.8K | $725.2K | $802.8K | $72.8K | $183.9K | $294.3K | $493.6K | $598.6K | $178.6K | $216.2K | $239.0K | $235.6K | |||||||
| Intangible Assets Net Excluding Goodwill | $1.5M | $1.6M | $1.6M | $1.7M | $1.7M | $1.7M | $1.8M | $1.9M | $2.0M | $2.0M | $2.1M | $2.4M | $2.4M | $1.0M | $1.1M | $1.1M | $1.1M | |||||||
| Property Plant And Equipment Net | $764.3K | $881.5K | $992.2K | $1.1M | $1.2M | $1.3M | $1.4M | $1.5M | $615.1K | $753.2K | $703.9K | $802.4K | $904.3K | $1.0M | $1.1M | $304.9K | $326.6K | $347.9K | $373.8K | $384.5K | ||||
| Other Assets Noncurrent | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $101.8K | $147.5K | $171.1K | $171.1K | $108.6K | $109.2K | $8.6K | $14.7K | $14.7K | $14.0K | ||||||
| Inventory Net | $947.9K | $890.8K | $961.2K | $814.0K | $1.1M | $1.2M | $1.2M | $744.8K | $1.1M | $1.3M | $1.6M | $1.8M | $1.4M | $988.8K | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $3.2M | $8.0M | -$1.3M | $1.2M | ||||||||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $103.5K | $75.9K | $90.4K | $95.6K | $93.1K | $94.5K | $91.9K | $90.4K | $99.5K | |||||||||||||||
| Inventory Write Down | $208.7K | $208.7K | $0.00 | $0.00 | $0.00 | $170.5K | $92.9K | $576.8K | ||||||||||||||||
| Repayments Of Long Term Capital Lease Obligations | $98.7K | $100.9K | $17.4K | $16.2K | ||||||||||||||||||||
| Operating Lease Expense | $99.5K | $25.9K | $20.7K | $7.2K | ||||||||||||||||||||
| Additional Paid In Capital Common Stock | $38.4M | $38.6M | $39.3M | $34.9M | $34.8M | $34.8M | $37.5M | $35.8M | ||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $187.2K | |||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$1.7M | -$988.6K | -$2.2M | $3.2M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $119.3K | $137.7K | $278.2K | $697.9K | $610.2K | $994.4K |
| Net Cash Provided By Used In Operating Activities | -$7.8M | -$7.0M | -$7.3M | -$15.6M | -$9.8M | -$7.4M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$249.7K | $45.3K | -$806.5K | -$811.6K | $346.7K | $467.4K |
| Depreciation Depletion And Amortization | $212.8K | $219.6K | $202.2K | $185.7K | $120.9K | $112.4K |
| Increase Decrease In Accounts Receivable | $114.7K | $92.4K | $219.1K | $40.0K | -$40.2K | -$17.3K |
| Increase Decrease In Prepaid Expenses Other | -$174.0K | -$20.3K | -$299.2K | -$190.7K | $823.2K | $126.6K |
| Net Cash Provided By Used In Financing Activities | $12.3M | $4.7M | $10.7M | $15.1M | $10.9M | -$31.0K |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $119.3K | $137.7K | $278.2K | |||
| Increase Decrease In Other Noncurrent Assets | -$4.9K | -$5.5K | $61.4K | $14.2K | ||
| Increase Decrease In Inventories | -$283.2K | -$66.2K | -$565.6K | $2.0M | ||
| Net Cash Provided By Used In Investing Activities | -$9.3K | -$661.8K | -$673.0K | -$1.7K | $3.8M | |
| Proceeds From Sale Of Short Term Investments | $42.3K | $42.1K | $42.3K | $3.9M | ||
| Payments To Acquire Property Plant And Equipment | $9.3K | $160.0K | $39.1K | $1.7K | $42.6K | |
| Payments To Acquire Short Term Investments | $42.3K | $42.1K | $42.3K | $43.6K | ||
| Employee Benefits And Share Based Compensation | $278.2K | $697.9K | $610.2K | $994.4K | ||
| Payments Of Financing Costs | $1.3M | $1.8M | $1.6M | $31.0K | ||
| Increase Decrease In Operating Lease Liability | -$429.9K | -$397.4K | -$426.6K | |||
| Proceeds From Issuance Of Private Placement | $8.1M | $5.2M | $10.7M | $6.0M | ||
| Proceeds From Issuance Of Common Stock | $12.0M | $17.1M | $12.5M | |||
| Increase Decrease In Deferred Revenue | $16.2K | -$5.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $20.2K | $29.0K | $25.2K | $50.4K | $70.6K | $116.7K | $195.1K | $214.8K | $111.1K | $207.3K | $96.6K | $85.4K | $203.9K | $284.0K | $350.5K | |||||
| Net Cash Provided By Used In Operating Activities | -$1.6M | -$1.8M | -$2.2M | -$2.3M | -$2.7M | -$1.4M | -$2.4M | |||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$274.1K | -$642.4K | -$562.5K | -$159.3K | -$469.2K | $160.7K | -$147.7K | |||||||||||||
| Depreciation Depletion And Amortization | $53.2K | $54.6K | $54.8K | $49.0K | $28.5K | $28.0K | $30.2K | |||||||||||||
| Increase Decrease In Accounts Receivable | -$122.2K | -$67.6K | -$94.5K | -$72.9K | $2.9K | $5.6K | -$34.0K | |||||||||||||
| Increase Decrease In Prepaid Expenses Other | -$328.9K | -$283.0K | -$440.6K | -$634.4K | $31.7K | -$84.1K | ||||||||||||||
| Net Cash Provided By Used In Financing Activities | -$137.2K | $838.2K | $5.4M | $10.9M | -$64.6K | |||||||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | -$25.3K | -$20.2K | $40.5K | -$23.2K | -$29.0K | $55.3K | $18.3K | $25.2K | $50.4K | $70.6K | $116.7K | |||||||||
| Increase Decrease In Other Noncurrent Assets | -$3.1K | -$5.5K | -$6.0K | $14.0K | ||||||||||||||||
| Increase Decrease In Inventories | -$70.4K | -$24.3K | -$390.3K | -$135.6K | ||||||||||||||||
| Net Cash Provided By Used In Investing Activities | -$250.0K | $3.7M | ||||||||||||||||||
| Proceeds From Sale Of Short Term Investments | $21.0K | $21.3K | $21.3K | $3.8M | ||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $250.0K | $32.5K | ||||||||||||||||||
| Payments To Acquire Short Term Investments | $21.0K | $21.3K | $21.3K | $26.1K | ||||||||||||||||
| Employee Benefits And Share Based Compensation | $116.7K | $111.1K | $85.4K | $350.5K | ||||||||||||||||
| Payments Of Financing Costs | $571.3K | $1.1M | $64.6K | |||||||||||||||||
| Increase Decrease In Operating Lease Liability | -$107.4K | -$106.5K | -$98.7K | |||||||||||||||||
| Proceeds From Issuance Of Private Placement | $1.0M | |||||||||||||||||||
| Proceeds From Issuance Of Common Stock | $6.0M | $12.0M | ||||||||||||||||||
| Increase Decrease In Deferred Revenue | $15.7K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$8.36 | -$20.14 | -$3.25 | -$33.17 | -$37.96 | -$1.71 |
| Weighted Average Number Of Diluted Shares Outstanding | 976.0K | 381.1K | 2.4M | 560.8K | 268.8K | 5.2M |
| Earnings Per Share Basic | $-8.36 | $-20.14 | $-3.25 | $-33.17 | $-37.96 | |
| Weighted Average Number Of Shares Outstanding Basic | 976.0K | 381.1K | 2.4M | 560.8K | ||
| Common Stock Shares Outstanding | 445.9K | 3.3M | 650.7K | 322.0K | 5.2M | |
| Common Stock Shares Issued | 445.9K | 3.3M | 650.7K | 322.0K | 5.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.51 | -$0.44 | -$1.94 | -$3.64 | -$2.71 | -$3.58 | -$3.71 | -$15.24 | -$0.60 | -$0.91 | -$4.06 | -$6.14 | -$7.73 | -$6.17 | -$0.41 | -$0.37 | -$0.31 | -$0.39 | -$0.48 | -$0.54 | |
| Weighted Average Number Of Diluted Shares Outstanding | 4.0M | 4.0M | 1.1M | 706.5K | 620.1K | 480.6K | 398.7K | 166.4K | 3.3M | 2.3M | 865.6K | 566.1K | 553.9K | 481.9K | 7.5M | 6.1M | 5.2M | 5.2M | 5.2M | 5.2M | |
| Earnings Per Share Basic | $-0.51 | $-0.44 | $-1.94 | $-3.64 | $-2.71 | $-3.58 | $-3.71 | $-15.24 | $-0.60 | $-0.91 | $-4.06 | $-6.14 | $-7.73 | $-6.17 | |||||||
| Weighted Average Number Of Shares Outstanding Basic | 4.0M | 4.0M | 1.1M | 706.5K | 620.1K | 480.6K | 398.7K | 166.4K | 3.3M | 2.3M | 865.6K | 566.1K | 553.9K | 481.9K | |||||||
| Common Stock Shares Outstanding | 2.8M | 2.6M | 2.0M | 1.2M | 724.2K | 667.0K | 6.3M | 5.7M | 3.3M | 3.3M | 1.6M | 908.8K | 14.3M | 14.1M | 10.3M | 8.1M | 7.0M | 5.2M | |||
| Common Stock Shares Issued | 2.8M | 2.6M | 2.0M | 1.2M | 724.2K | 667.0K | 6.3M | 5.7M | 3.3M | 3.3M | 1.6M | 908.8K | 14.3M | 14.1M | 10.3M | 8.1M | 7.0M | 5.2M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Depreciation And Amortization | $212.8K | $219.6K | $202.2K | $185.7K | $120.9K | $112.4K |
| Investment Income Interest | $155.9K | $527.9K | $492.4K | $96.1K | $16.0K | $129.5K |
| Foreign Currency Transaction Gain Loss Unrealized | -$61.9K | -$48.2K | -$117.6K | $430.4K | -$419.8K | |
| Foreign Currency Transaction Gain Loss Before Tax | -$28.5K | -$61.9K | -$117.6K | -$163.1K | $82.2K | |
| Stock Issued During Period Value New Issues | $884.0K | $562.2K | $2.0M | $2.9M | ||
| Stock Issued During Period Value Issued For Private Placement | $5.2M | $12.0M | $12.0M | $4.5M | ||
| Additional Paid In Capital | $31.7M | $21.5M | $17.8M | |||
| Unrealized Loss On Foreign Currency Derivatives Before Tax | $75.9K | $12.3K | $1.2K | $1.8K | ||
| Share Issuance Costs | -$2.9M | -$1.6M | ||||
| Exercise Of Prefunded Warrants | $646.00 | $315.00 | ||||
| Unrealized Gain On Foreign Exchange | -$1.8K | $445.00 | ||||
| Interest Income Short Term Investment Other | $1.3K | $803.00 | $115.00 | |||
| Stock Issued1 | $325.7K | $691.5K | $3.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation And Amortization | $53.2K | $53.2K | $52.3K | $53.2K | $54.6K | $54.8K | $55.2K | $54.8K | $50.7K | $49.0K | $49.0K | $53.3K | $49.8K | $28.5K | $27.4K | $36.8K | $28.0K | $27.1K | $28.2K | $30.2K | |
| Investment Income Interest | $74.4K | $93.8K | $16.6K | $30.5K | $57.1K | $121.5K | $166.8K | $136.0K | $155.5K | $115.8K | $72.6K | $31.0K | $26.3K | $5.1K | $3.8K | $3.1K | $4.3K | $26.3K | $40.5K | $58.4K | |
| Foreign Currency Transaction Gain Loss Unrealized | -$1.4K | -$5.3K | -$48.2K | $59.9K | -$48.5K | -$2.7K | $20.2K | -$96.8K | $33.0K | $3.0K | -$84.1K | $301.0K | $129.4K | -$717.5K | $350.2K | -$318.5K | |||||
| Foreign Currency Transaction Gain Loss Before Tax | $18.1K | -$57.0K | -$22.2K | -$47.8K | $19.3K | -$48.2K | $59.9K | -$48.5K | -$96.8K | $33.0K | $3.0K | -$84.1K | $28.5K | -$194.8K | -$39.5K | $153.9K | -$27.2K | $15.9K | |||
| Stock Issued During Period Value New Issues | $137.2K | $15.1K | $57.6K | $191.8K | $562.2K | $5.4M | $5.3M | $6.1M | |||||||||||||
| Stock Issued During Period Value Issued For Private Placement | $2.9M | $396.2K | $1.0M | $5.2M | $6.0M | $6.0M | $12.0M | $4.5M | |||||||||||||
| Additional Paid In Capital | $38.1M | $35.7M | $35.7M | $38.4M | $35.2M | $26.5M | $27.0M | $29.2M | $21.3M | $17.9M | $17.8M | ||||||||||
| Unrealized Loss On Foreign Currency Derivatives Before Tax | $5.3K | $2.0K | $2.8K | ||||||||||||||||||
| Share Issuance Costs | -$881.9K | -$1.1M | -$2.0M | -$508.7K | -$1.1M | ||||||||||||||||
| Exercise Of Prefunded Warrants | $174.00 | $53.00 | $419.00 | $176.00 | $139.00 | ||||||||||||||||
| Unrealized Gain On Foreign Exchange | -$2.8K | -$1.3K | |||||||||||||||||||
| Interest Income Short Term Investment Other | $519.00 | $538.00 | $120.00 | ||||||||||||||||||
| Stock Issued1 | $739.9K |
Most recent annual filing with the SEC: September 23, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.